Category: Wellness

  • How many glasses of water does a average human body need and…

    How many glasses of water does a average human body need to survive a day and why

  • How many glasses of water you need per day

    How many glasses of water does a average human body meed every day

  • How can people improve their wellness?

    Describe simple ways to stay healthy and feel better every day. Talk about healthy food, exercise, sleep, and managing stress. Explain how these habits can help a persons body and mind.

  • Bagaimana cara jantung berkerja?

    Mari belajar bagaimana jantung berkerja,,berkembang dan bagaimana jantung memproses darah,hingga darah mengalir ke dalam seluruh tubuh,sehingga tubuh merasakan oksigen yang cukup

  • Bagaimana cara Jantung berkerja?

    Menjelaskan bagaimana cara jantung berkerja dan bagaimana proses jantung mengalirkan darah ke dalam seluruh tubuh hingga tubuh menerima darah secara merata

  • Benefits of the human well being due to a balance diet and r…

    Specific details are the benefits and the causes of not taking care of yourself

  • health care ethics ped-303-01

    safer drug consumption services is the topic

    and the research question is it ethical to implement safer drug consumption services as a public health effort

    also need google slides to match the paper

  • Wellness Question

    Use the following research question and guidelines to write a 5-7 page research paper with at least 4 creditable sources: Does the ethical obligation to protect athletes from concussions outweigh their right to decide whether to wear protective headgear in competitive sports?

  • COMBATTING DIABETES AMONG CHILDREN TODAY

    Click on the link below about The Importance of Mental Health among College Students. Think about your own mental health and that of your friends at GSU. Write about your feelings in a 2 page summary including your suggestions based on the report below. Should be your feelings!

  • Healthcare Ethics (PED-303-01)

    Topic; Human Participating in drug trials

    Research Question: Ill patients should have the fundamental right to access unproven experimental drugs, even if it may compromise the scientific integrity of the clinicla trial process

    Affirmative Article;

    1.

    1. The terminally ill, access to investigational drugs, and FDA Rules | Journal of Ethics | American Medical Association. (n.d.).

    A. Human participating in drug trials

    B. Is it ethical to provide terminally ill patients access to experimental drugs?

    This research question is really controversial it can be debateable as well. The issue of giving experimental drugs to terminally ill patients raises many ethical questions. it may help patients gain more time or improve their quality of life. Experimental drugs may cause serious side effects or worsen the patients condition

    C. The AFFIRMATIVE position in this debate or controversial would argue in favor of providing terminally ill patients to access drugs emphasizing the patients rights to potentially life saving treatment.

    4: Article Summary

    • In Paragraph 1: Fully describe what the main points of the article include.

    Abigail Burroughs was diagnosed with head and neck cancer in her late teens. After a year of treatment, standard therapies failed, and her doctors suggested an experimental cancer drug meant for colon cancer patients. However, she was unable to participate in a clinical trial due to her declining health and died at 21. To honor her, her father created the Abigail Alliance to advocate for terminally ill patients’ access to experimental drugs. He sued the FDA for expanded access, raising legal questions about the right to experimental therapies and the risks terminally ill patients might take. The case U. S. v Rutherford (1979) involved patients seeking to use Laetrile, a drug blocked by the FDA, believing it was their last hope.

    • In Paragraph 2: You MUST also provide information to describe how this article takes the AFFIRMATIVE position of the Debatable Research Question on this topic.

    The U. S. Court of Appeals for the District of Columbia considered the case Abigail Alliance for Better Access to Developmental Drugs v. Von Eschenbach nearly 30 years after a similar issue arose. The alliance challenged the FDA’s procedures for accessing developing drugs for terminally ill patients, claiming they were ineffective and demanded greater rights. A three-judge panel ruled in favor of the alliance, asserting that terminally ill patients have a fundamental right to access experimental therapies after phase I testing. They based this on the due process clause of the Fifth Amendment, highlighting a tradition of individual control over ones body. The court noted that while drug regulation is relatively new, the right to make personal medical decisions has deep historical roots.

    Dissenting Article

    1. Article Link

    2. APA Reference

    Zettler, M. E., Jeune-Smith, Y., Feinberg, B. A., Phillips, E. G., & Gajra, A. (2021, November). Expanded access and right to try requests: The Community Oncologists Experience. JCO oncology practice.

    3. Research Question Information

    A. Exact Approved Debatable Research Question:
    Should terminally ill patients access unproven experimental drugs?

    B. Explanation of the Dissenting Position:
    The dissenting position argues that terminally ill patients should not have broad access to unproven experimental drugs outside of controlled clinical trials. This perspective maintains that such access may expose vulnerable patients to serious safety risks, false hope, financial exploitation, and treatments that have not been proven effective or safe through proper scientific testing.

    Paragraph 1:
    The article examines how the U. S. obtain investigational drugs for cancer patients who have run out of approved treatments using the Expanded Access (EA) program and the Right To Try law. A survey of 238 physicians found that 46% attempted EA and only 14% attempted Right To Try, with higher success rates for EA. Many physicians also had gaps in understanding, such as underestimating the FDA approval rate for EA requests.

    Paragraph 2:
    This article challenges the belief that Right To Try laws significantly improve access to investigational treatments for cancer patients. It argues that while supporters say these laws reduce regulatory barriers, data reveals that Right To Try is used less frequently and is less successful than the existing Expanded Access (EA) pathway. Many physicians lack understanding of the differences between these pathways.